Home > Insider Trading > Filing (0001213900-23-097671)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1821586	Moonlake Immunotherapeutics	MLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1920545	Matthias Bodenstedt	C/O Moonlake Immunotherapeutics Dorfstrasse 29 Zug V8 6300	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares, Par Value $0.0001 Per Share	Disposition	2023-12-19	94,736	$59.22	526,167	No	4	S	Direct
Class A Ordinary Shares, Par Value $0.0001 Per Share	Disposition	2023-12-20	5,264	$58.34	520,903	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2023.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $56.655 to $60.13. Upon request by the staff of the U.S. Securities and Exchange Commission (the "Commission"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $57.53 to $59.27. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.